awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37139427-34F4BD2C-D9DA-4A90-9A3E-2E3C1BEC5775
Q37139427-34F4BD2C-D9DA-4A90-9A3E-2E3C1BEC5775
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37139427-34F4BD2C-D9DA-4A90-9A3E-2E3C1BEC5775
Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes.
P2860
Q37139427-34F4BD2C-D9DA-4A90-9A3E-2E3C1BEC5775
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37139427-34F4BD2C-D9DA-4A90-9A3E-2E3C1BEC5775
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fe25a43f3a009f00f9458aa57ec406ac1d50ef7a
P2860
Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.